University of Michigan Regent Ron Weiser and his wife, Eileen, of Ann Arbor, have committed $30 million to the university for diabetes research and the development of life-changing diabetes therapies at Michigan Medicine, in collaboration with other U-M schools and units for diabetes research.
The gift — named for Weiser’s daughter who has two sons and a husband with Type 1 diabetes — will be used to establish the Elizabeth Weiser Caswell Diabetes Institute, pending approval by the Board of Regents, and advance U-M faculty-led collaborative projects that have the potential for rapid clinical application.
“Elizabeth has been a relentless educator and advocate for people with diabetes and for diabetes research,” Weiser says. “Our family hopes that the collaboration among physicians, researchers, innovators, and advocates across campus will allow the work she’s done — and continues to do — to be rewarded with cures for diabetes.”
She has served on behalf of the diabetes nonprofit JDRF and was appointed vice-chair elect of the JDRF International Research Committee.
The Elizabeth Weiser Caswell Diabetes Institute will centralize and coordinate campus resources — anchored by a group of more than 250 world-renowned researchers in diabetes, diabetic complications, obesity, and metabolism — and allow U-M to bring new depth and discovery to the quest for answers to diabetes.
“This is one of the most important things that has happened for diabetes research, not just for the University of Michigan, but for the whole country,” says Martin Myers Jr., director of the new institute. “The institute is built on the idea that we can’t only study one aspect of diabetes, but rather that we need to work together to attack every piece of this disease at the same time. Thus, we will simultaneously work toward making designer insulin-producing beta cells as a therapy for diabetes, seek to understand how to block the onset of Type 1 and Type 2 diabetes, and focus on how to improve clinical care and access to current life-saving therapies.”
And, to ensure that a new generation of researchers are trained to continue investigations that mitigate the impact of T1D, Elizabeth and her husband, Trey, also partnered with Ron and Eileen Weiser to establish the Caswell Family Fellowship in pediatric endocrinology, part of the $30 million commitment.
“The Weiser family has a long history of championing the work of faculty and teams at the University of Michigan through their generosity and proliferation of vital partnerships,” says Mark Schlissel, president of U-M. “This gift will ensure that U-M is able to translate scientific discoveries into treatments for diabetes that save lives in our community and beyond.
“I am personally touched by the way this family has translated their personal experience with diabetes into hope for all people and grateful for their confidence in U-M’s promise to make a difference.”
Ron and Eileen Weiser are longstanding U-M alumni, volunteers and donors, committing more than $100 million to the university to date. In addition to Ron Weiser’s service on the U-M Board of Regents, they both served as vice chairs of the Victors for Michigan campaign and support a wide range of programs across all three campuses of the university.
These include the Weiser Center for Real Estate, Weiser Diplomacy Center, Weiser Center for Emerging Democracies, Weiser Center for Europe and Eurasia, Michigan Medicine’s Mary H. Weiser Food Allergy Center and Chad Carr Pediatric Brain Tumor Cancer Center, among other programs. The College of Literature, Science, and the Arts; Michigan Medicine; School of Music, Theatre and Dance; UM-Dearborn; Ross School of Business; Ford School of Public Policy; and dozens of other units have been beneficiaries of the Weisers’ generosity.
The Elizabeth Weiser Caswell Diabetes Institute will build on best practices of the standout programs developed at U-M and other top institutions. As part of the top public university in research spending in the United States, and in partnership with 20 divisions and departments within Michigan Medicine and 14 schools and units across the U-M campus that focus on diabetes care and research, the Elizabeth Weiser Caswell Diabetes Institute will strengthen U-M’s leadership nationally and globally in this space. Several national and international collaborators will work with the U-M and Michigan Medicine teams.
“This gift is transformational,” says Marschall Runge, executive vice president for medical affairs, dean of the U-M Medical School, and CEO of Michigan Medicine. “We are immensely grateful to the Weisers for opening the doors that enable our physicians and researchers to push the boundaries that will transition cutting-edge discoveries in diabetes investigations into life-saving therapies for children and adults.”